_id
690db3beccc777a4e85d0d04
Ticker
AVR
Name
Anteris Technologies Global Corp. Common Stock
Exchange
NASDAQ
Address
Toowong Tower, Toowong, QLD, Australia, 4066
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://anteristech.com
Description
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Last Close
4.92
Volume
240994
Current Price
5.58
Change
0.47
Last Updated
2026-01-20T16:02:21.253Z
Image
data:image/webp;base64,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
Ipo Date
2024-12-13T00:00:00.000Z
Market Cap
156138784
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.75
Target Price
16.5
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
429000
Cost Of Revenue
123000
Gross Profit
306000
Operating Expenses
22571000
Operating Income
-22265000
Interest Expense
15000
Pretax Income
-22209000
Net Income
-22244000
Eps
-0.9434640092911101
Dividends Per Share
-
Shares Outstanding
41197570
Income Tax Expense
-
EBITDA
-21777000
Operating Margin
-5189.97668997669
Total Other Income Expense Net
56000
Cash
9119000
Short Term Investments
-
Receivables
234000
Inventories
436000
Total Current Assets
11224000
Property Plant Equipment
7266000
Total Assets
19074000
Payables
4276000
Short Term Debt
720000
Long Term Debt
-
Total Liabilities
15715000
Equity
3698000
Bs_currency_symbol
-
Depreciation
417000
Change In Working Capital
1398000
Cash From Operations
-18252000
Capital Expenditures
772000
Cash From Investing
-772000
Cash From Financing
-294000
Net Change In Cash
-19319000
Cf_currency_symbol
-
PE
-
PB
35.575813596538666
ROE
-601.51433207139
ROA
-116.61948201740589
FCF
-19024000
Fcf Percent
-44.344988344988344
Piotroski FScore
1
Health Score
9
Deep Value Investing Score
1.5
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
429000
Quarters > 0 > income Statement > cost Of Revenue
123000
Quarters > 0 > income Statement > gross Profit
306000
Quarters > 0 > income Statement > operating Expenses
22571000
Quarters > 0 > income Statement > operating Income
-22265000
Quarters > 0 > income Statement > interest Expense
15000
Quarters > 0 > income Statement > pretax Income
-22209000
Quarters > 0 > income Statement > net Income
-22244000
Quarters > 0 > income Statement > eps
-0.9434640092911101
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
23576946
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-21777000
Quarters > 0 > income Statement > operating Margin
-5189.97668997669
Quarters > 0 > income Statement > total Other Income Expense Net
56000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
9119000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
234000
Quarters > 0 > balance Sheet > inventories
436000
Quarters > 0 > balance Sheet > total Current Assets
11224000
Quarters > 0 > balance Sheet > property Plant Equipment
7266000
Quarters > 0 > balance Sheet > total Assets
19074000
Quarters > 0 > balance Sheet > payables
4276000
Quarters > 0 > balance Sheet > short Term Debt
720000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
15715000
Quarters > 0 > balance Sheet > equity
3698000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-22244000
Quarters > 0 > cash Flow > depreciation
417000
Quarters > 0 > cash Flow > change In Working Capital
1398000
Quarters > 0 > cash Flow > cash From Operations
-18252000
Quarters > 0 > cash Flow > capital Expenditures
772000
Quarters > 0 > cash Flow > cash From Investing
-772000
Quarters > 0 > cash Flow > cash From Financing
-294000
Quarters > 0 > cash Flow > net Change In Cash
-19319000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.9434640092911101
Quarters > 0 > ratios > PB
35.575813596538666
Quarters > 0 > ratios > ROE
-601.51433207139
Quarters > 0 > ratios > ROA
-116.61948201740589
Quarters > 0 > ratios > FCF
-19024000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-44.344988344988344
Quarters > 0 > health Score
9
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
618000
Quarters > 1 > income Statement > cost Of Revenue
148000
Quarters > 1 > income Statement > gross Profit
470000
Quarters > 1 > income Statement > operating Expenses
21354000
Quarters > 1 > income Statement > operating Income
-20884000
Quarters > 1 > income Statement > interest Expense
22000
Quarters > 1 > income Statement > pretax Income
-21062000
Quarters > 1 > income Statement > net Income
-20834000
Quarters > 1 > income Statement > eps
-0.8836598260012132
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
23576946
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-20466000
Quarters > 1 > income Statement > operating Margin
-3379.2880258899677
Quarters > 1 > income Statement > total Other Income Expense Net
-178000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
28438000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
687000
Quarters > 1 > balance Sheet > inventories
449000
Quarters > 1 > balance Sheet > total Current Assets
32212000
Quarters > 1 > balance Sheet > property Plant Equipment
7054000
Quarters > 1 > balance Sheet > total Assets
39878000
Quarters > 1 > balance Sheet > payables
5398000
Quarters > 1 > balance Sheet > short Term Debt
1068000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
15846000
Quarters > 1 > balance Sheet > equity
24406000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-20834000
Quarters > 1 > cash Flow > depreciation
418000
Quarters > 1 > cash Flow > change In Working Capital
-768000
Quarters > 1 > cash Flow > cash From Operations
-19535000
Quarters > 1 > cash Flow > capital Expenditures
537000
Quarters > 1 > cash Flow > cash From Investing
-537000
Quarters > 1 > cash Flow > cash From Financing
-442000
Quarters > 1 > cash Flow > net Change In Cash
-20517000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.8836598260012132
Quarters > 1 > ratios > PB
5.39045147422765
Quarters > 1 > ratios > ROE
-85.36425469146931
Quarters > 1 > ratios > ROA
-52.24434525302172
Quarters > 1 > ratios > FCF
-20072000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-32.4789644012945
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
556000
Quarters > 2 > income Statement > cost Of Revenue
207000
Quarters > 2 > income Statement > gross Profit
349000
Quarters > 2 > income Statement > operating Expenses
22129000
Quarters > 2 > income Statement > operating Income
-21780000
Quarters > 2 > income Statement > interest Expense
26000
Quarters > 2 > income Statement > pretax Income
-21931000
Quarters > 2 > income Statement > net Income
-21864000
Quarters > 2 > income Statement > eps
-0.9273465698229109
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
23576946
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-21377000
Quarters > 2 > income Statement > operating Margin
-3917.26618705036
Quarters > 2 > income Statement > total Other Income Expense Net
-151000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
48955000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
189000
Quarters > 2 > balance Sheet > inventories
364000
Quarters > 2 > balance Sheet > total Current Assets
52982000
Quarters > 2 > balance Sheet > property Plant Equipment
5668000
Quarters > 2 > balance Sheet > total Assets
58792000
Quarters > 2 > balance Sheet > payables
5479000
Quarters > 2 > balance Sheet > short Term Debt
1455000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
15679000
Quarters > 2 > balance Sheet > equity
43259000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-21864000
Quarters > 2 > cash Flow > depreciation
403000
Quarters > 2 > cash Flow > change In Working Capital
-174000
Quarters > 2 > cash Flow > cash From Operations
-21489000
Quarters > 2 > cash Flow > capital Expenditures
248000
Quarters > 2 > cash Flow > cash From Investing
1110000
Quarters > 2 > cash Flow > cash From Financing
-1091000
Quarters > 2 > cash Flow > net Change In Cash
-21503000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.9273465698229109
Quarters > 2 > ratios > PB
3.0412020314847776
Quarters > 2 > ratios > ROE
-50.54208372824153
Quarters > 2 > ratios > ROA
-37.18873316097428
Quarters > 2 > ratios > FCF
-21737000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-39.09532374100719
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
536112
Quarters > 3 > income Statement > cost Of Revenue
207758
Quarters > 3 > income Statement > gross Profit
328354
Quarters > 3 > income Statement > operating Expenses
21390592
Quarters > 3 > income Statement > operating Income
-21062238
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-19200950
Quarters > 3 > income Statement > net Income
-19375182
Quarters > 3 > income Statement > eps
-0.8217850607114254
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
23576946
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-21114487
Quarters > 3 > income Statement > operating Margin
-3928.7010923090697
Quarters > 3 > income Statement > total Other Income Expense Net
1861288
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
70458000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
383000
Quarters > 3 > balance Sheet > inventories
513000
Quarters > 3 > balance Sheet > total Current Assets
74651000
Quarters > 3 > balance Sheet > property Plant Equipment
5859000
Quarters > 3 > balance Sheet > total Assets
80699000
Quarters > 3 > balance Sheet > payables
5889000
Quarters > 3 > balance Sheet > short Term Debt
750000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
18017000
Quarters > 3 > balance Sheet > equity
62761000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-19375182
Quarters > 3 > cash Flow > depreciation
404292
Quarters > 3 > cash Flow > change In Working Capital
-241682
Quarters > 3 > cash Flow > cash From Operations
-18237311
Quarters > 3 > cash Flow > capital Expenditures
363099
Quarters > 3 > cash Flow > cash From Investing
-363568
Quarters > 3 > cash Flow > cash From Financing
78400308
Quarters > 3 > cash Flow > net Change In Cash
59840384
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.8217850607114254
Quarters > 3 > ratios > PB
2.096196024282596
Quarters > 3 > ratios > ROE
-30.87137234907028
Quarters > 3 > ratios > ROA
-24.009197139989343
Quarters > 3 > ratios > FCF
-18600410
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-34.695007759572626
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2703000
Annuals > 0 > income Statement > cost Of Revenue
1437000
Annuals > 0 > income Statement > gross Profit
1266000
Annuals > 0 > income Statement > operating Expenses
79638000
Annuals > 0 > income Statement > operating Income
-78372000
Annuals > 0 > income Statement > interest Expense
82000
Annuals > 0 > income Statement > pretax Income
-75967000
Annuals > 0 > income Statement > net Income
-76291000
Annuals > 0 > income Statement > eps
-3.7669137964754613
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
20252919
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-76865000
Annuals > 0 > income Statement > operating Margin
-2899.4450610432855
Annuals > 0 > income Statement > total Other Income Expense Net
2405000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
70458000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
383000
Annuals > 0 > balance Sheet > inventories
513000
Annuals > 0 > balance Sheet > total Current Assets
74651000
Annuals > 0 > balance Sheet > property Plant Equipment
5859000
Annuals > 0 > balance Sheet > total Assets
80699000
Annuals > 0 > balance Sheet > payables
5889000
Annuals > 0 > balance Sheet > short Term Debt
750000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
18017000
Annuals > 0 > balance Sheet > equity
62761000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-76291000
Annuals > 0 > cash Flow > depreciation
1972000
Annuals > 0 > cash Flow > change In Working Capital
-982000
Annuals > 0 > cash Flow > cash From Operations
-61241000
Annuals > 0 > cash Flow > capital Expenditures
2266000
Annuals > 0 > cash Flow > cash From Investing
-2280000
Annuals > 0 > cash Flow > cash From Financing
112833000
Annuals > 0 > cash Flow > net Change In Cash
49369000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-3.7669137964754613
Annuals > 0 > ratios > PB
1.8006610477844522
Annuals > 0 > ratios > ROE
-121.55797390098945
Annuals > 0 > ratios > ROA
-94.53772661371268
Annuals > 0 > ratios > FCF
-63507000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-23.495005549389568
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2734821
Annuals > 1 > income Statement > cost Of Revenue
1858021
Annuals > 1 > income Statement > gross Profit
876800
Annuals > 1 > income Statement > operating Expenses
49016788
Annuals > 1 > income Statement > operating Income
-48139988
Annuals > 1 > income Statement > interest Expense
67089
Annuals > 1 > income Statement > pretax Income
-46763397
Annuals > 1 > income Statement > net Income
-46021841
Annuals > 1 > income Statement > eps
-1.2805252258386632
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
35939816
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-45538585
Annuals > 1 > income Statement > operating Margin
-1760.2610189112927
Annuals > 1 > income Statement > total Other Income Expense Net
1376591
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
21027219
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1845382
Annuals > 1 > balance Sheet > inventories
442348
Annuals > 1 > balance Sheet > total Current Assets
24221734
Annuals > 1 > balance Sheet > property Plant Equipment
5478291
Annuals > 1 > balance Sheet > total Assets
30527440
Annuals > 1 > balance Sheet > payables
3139140
Annuals > 1 > balance Sheet > short Term Debt
668921
Annuals > 1 > balance Sheet > long Term Debt
93841
Annuals > 1 > balance Sheet > total Liabilities
11629367
Annuals > 1 > balance Sheet > equity
19300908
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-46763397
Annuals > 1 > cash Flow > depreciation
1157723
Annuals > 1 > cash Flow > change In Working Capital
3986243
Annuals > 1 > cash Flow > cash From Operations
-34631516
Annuals > 1 > cash Flow > capital Expenditures
2394908
Annuals > 1 > cash Flow > cash From Investing
-2581673
Annuals > 1 > cash Flow > cash From Financing
49339774
Annuals > 1 > cash Flow > net Change In Cash
11735685
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.2805252258386632
Annuals > 1 > ratios > PB
10.390400973881643
Annuals > 1 > ratios > ROE
-238.44391673179314
Annuals > 1 > ratios > ROA
-150.7556513091173
Annuals > 1 > ratios > FCF
-37026424
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-13.538883897702995
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3200711
Annuals > 2 > income Statement > cost Of Revenue
2902328
Annuals > 2 > income Statement > gross Profit
298383
Annuals > 2 > income Statement > operating Expenses
31412658
Annuals > 2 > income Statement > operating Income
-31114275
Annuals > 2 > income Statement > interest Expense
648709
Annuals > 2 > income Statement > pretax Income
-30563800
Annuals > 2 > income Statement > net Income
-30563800
Annuals > 2 > income Statement > eps
-0.8504161512679976
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
35939816
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-29141014
Annuals > 2 > income Statement > operating Margin
-972.1051041471723
Annuals > 2 > income Statement > total Other Income Expense Net
550475
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9293057
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1514566
Annuals > 2 > balance Sheet > inventories
355624
Annuals > 2 > balance Sheet > total Current Assets
12239675
Annuals > 2 > balance Sheet > property Plant Equipment
3138477
Annuals > 2 > balance Sheet > total Assets
15985506
Annuals > 2 > balance Sheet > payables
1726872
Annuals > 2 > balance Sheet > short Term Debt
513009
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
6952284
Annuals > 2 > balance Sheet > equity
9033222
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-30563800
Annuals > 2 > cash Flow > depreciation
774077
Annuals > 2 > cash Flow > change In Working Capital
-1746853
Annuals > 2 > cash Flow > cash From Operations
-29416702
Annuals > 2 > cash Flow > capital Expenditures
1665989
Annuals > 2 > cash Flow > cash From Investing
-992570
Annuals > 2 > cash Flow > cash From Financing
23271389
Annuals > 2 > cash Flow > net Change In Cash
-6101992
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.8504161512679976
Annuals > 2 > ratios > PB
22.20073560463808
Annuals > 2 > ratios > ROE
-338.34881950205585
Annuals > 2 > ratios > ROA
-191.19695053756823
Annuals > 2 > ratios > FCF
-31082691
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-9.711183233975202
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5830534
Annuals > 3 > income Statement > cost Of Revenue
3925362
Annuals > 3 > income Statement > gross Profit
1905172
Annuals > 3 > income Statement > operating Expenses
18765748
Annuals > 3 > income Statement > operating Income
-16860576
Annuals > 3 > income Statement > interest Expense
1034193
Annuals > 3 > income Statement > pretax Income
-17171057
Annuals > 3 > income Statement > net Income
-17171057
Annuals > 3 > income Statement > eps
-0.4777725350625056
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
35939816
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-15496777
Annuals > 3 > income Statement > operating Margin
-289.17721772997123
Annuals > 3 > income Statement > total Other Income Expense Net
-310481
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
15455182
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1852064
Annuals > 3 > balance Sheet > inventories
549820
Annuals > 3 > balance Sheet > total Current Assets
18749139
Annuals > 3 > balance Sheet > property Plant Equipment
1920911
Annuals > 3 > balance Sheet > total Assets
21433693
Annuals > 3 > balance Sheet > payables
2229073
Annuals > 3 > balance Sheet > short Term Debt
3830362
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10908758
Annuals > 3 > balance Sheet > equity
10524935
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-17171057
Annuals > 3 > cash Flow > depreciation
640087
Annuals > 3 > cash Flow > change In Working Capital
976405
Annuals > 3 > cash Flow > cash From Operations
-14438162
Annuals > 3 > cash Flow > capital Expenditures
582235
Annuals > 3 > cash Flow > cash From Investing
-886068
Annuals > 3 > cash Flow > cash From Financing
27418812
Annuals > 3 > cash Flow > net Change In Cash
12101457
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.4777725350625056
Annuals > 3 > ratios > PB
19.054195895746627
Annuals > 3 > ratios > ROE
-163.1464422345601
Annuals > 3 > ratios > ROA
-80.11245192324067
Annuals > 3 > ratios > FCF
-15020397
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.576161463083827
Annuals > 3 > health Score
16
Valuation > metrics > PE
-0.9434640092911101
Valuation > metrics > PB
35.575813596538666
Valuation > final Score
20
Valuation > verdict
1085.9% Overvalued
Profitability > metrics > ROE
-601.51433207139
Profitability > metrics > ROA
-198.1824661439772
Profitability > metrics > Net Margin
-51.85081585081585
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
4.24959437533802
Risk > metrics > Interest Coverage
-1484.3333333333333
Risk > final Score
-5931
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.2465972778222576
Liquidity > metrics > Quick Ratio
2.1593274619695757
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
26.095485257723503
Prev Valuations > 1
49.58797968515222
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-3749
Prev Risks > 1
-3291
Prev Risks > 2
16
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:26:45.456Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.56
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.62
Earnings History > 1 > eps Estimate
-0.57
Earnings History > 1 > eps Difference
-0.05
Earnings History > 1 > surprise Percent
-8.7719
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-11
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.58
Earnings History > 2 > eps Estimate
-0.53
Earnings History > 2 > eps Difference
-0.05
Earnings History > 2 > surprise Percent
-9.434
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-13
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.61
Earnings History > 3 > eps Estimate
-0.47
Earnings History > 3 > eps Difference
-0.14
Earnings History > 3 > surprise Percent
-29.7872
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.52
Earnings History > 4 > eps Estimate
-0.5638
Earnings History > 4 > eps Difference
0.0438
Earnings History > 4 > surprise Percent
7.7687
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-27
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-1.07
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-1.07
Earnings History > 5 > surprise Percent
-
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$16.5
Analyst Picks
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Anteris Technologies Global Corp. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.56
Date
2025-09-30
EPS Actual
-0.62
EPS Estimate
-0.57
EPS Difference
-0.05
Surprise Percent
-8.7719%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.